Table 1.
Organs involved in fibrosis |
Epigenetic mechanism |
||||||||
---|---|---|---|---|---|---|---|---|---|
Gene | Lungs | Skin | Liver | Kidney | Intestine | Methylation | Histone modification | miRNA | References |
Smad3 | ↑ | ↑ | ↓ | ↑ | ↑ | N/A | HDAC1 | miR-21, miR-154, miR-29 | 64, 69, 70, 75–77 |
Smad7 | ↓ | ↓ | ↓ | ↓ | ↓ | DNMT1 | N/A | miR-21, miR-17-5 p | 44, 78, 79 |
SOCS3 | ↓ | N/A | ↓ | ↓ | ↓ | DNMT1 | N/A | miR-19 b | 11, 12, 40 |
MMP | ↑ | ↑ | ↑ | ↑ | ↑ | Promoter | HDAC | miR-17, miR-18 a, b & miR-19 a, b, | 50, 51, 95 |
α-SMA | ↑ | ↑ | ↑ | ↑ | ↑ | CpG, DNMT1, DNMT3b | H3K4me1 | N/A | 39, 41 |
COL | ↑ | ↑ | ↑ | ↑ | ↑ | DNMT1, DNMT3b | H4 acetylation, Fli-1 acetylation, H3K4me1 | miR-18 a, b & miR-19 a, b, miR-29 | 38, 41, 54, 66, 67, 71, 72 |
VMP1 | N/A | N/A | N/A | N/A | ↑ | N/A | N/A | miR-21 | 42 |
TGF-β1 | ↑ | ↑ | ↑ | ↑ | ↑ | Smad7 methylation, Smad4 hypermethylation | H3K4me3↑, H2A.Z↑, ↓H3K9me2 and H3K9me3 on the promoters of ECM genes | miR-21, miR-17 & miR-19 a, b | 43, 44 |
COX2 | ↓ | ↑ | ↑/↓ | ↑ | ↓ | Promoter hypermethylation or hypomethylation | ↓histone H3 and H4 acetylation, ↑ in H3K9me3, H3K27me3, and DNA methylation | Reported mostly in cancer research, miR-101, miR-26 b, miR-146 a, miR-16 and miR-122 | 52, 38, 80–88 |
CXCL10 | ↓ | ↑ | ↑ | ↓ | ↑ | N/A | H3 | unknown | 53, 91–94 |
TIMP1 | ↑/↓ | ↓ | ↑ | ↑ | ↑ | DNMT1 | H3K4me1 | miR-17, miR-29, miR-1293 | 54, 95, 96 |
Fli-1 | ↓ | N/A | N/A | N/A | N/A | Promoter hypermethylation | P300-induced acetylation | N/A | 33, 89, 90 |
Spry-1 | ↓ | ↓ | ↓ | ↓ | ↓ | Promoter hypermethylation | HDAC↑ Spry-1 gene expression | miR-29, miR-21 | 66, 100 |
PTEN | ↓ | ↓ | ↓ | ↓ | ↓ | DNMT1-induced hypermethylation | Its interaction with histone H1 to keep chromatin condensation | miR-21 | 43, 97–99 |
PPAR-α | ↓ | ↓ | ↓ | ↓ | ↓ | Promoter hypermethylation | N/A | miR-21, miR-10 b, miR-33 a | 62–64, 101–105 |
STAT3 | ↑ | ↑ | ↑ | ↑ | ↑ | DNMT1, | HDACs, SET1, LSD1, EZH2 | miR-21, miR-17, miR-29, miR-98 | 43, 66–70, 106–109 |
Thy-1 | ↓ | ↑ | ↑ | ↓/↑ | ↑ | DNMT1, Hypermethylation | H3, HDAC inhibitor | N/A | 52, 53, 110–113 |
IL-27 | ↓/↑ | ↑ | ↓ | ↓/↑ | ↓ | N/A | N/A | N/A | 29, 114–117 |
NOD2 | ↓/↑ | N/A | ↑ | N/A | ↓ | DNA methylation | H3K4Me2 and H4Ac, H3K27Me3 histone modifications | miR-29, miR-192 | 29, 124–130 |
TNF-α | ↑ | ↑ | ↑ | ↑ | ↑ | DNA demethylation | Histone acetylation, H3K9 and H3K4 methylation | miR-23 a, miR-155, miR-346 | 29, 118–123 |
SMT1 | ↑ | N/A | ↑ | ↑ | ↓ | DNA methylation | N/A | N/A | 29, 131 |
IL-19 | ↑ | ↑ | N/A | ↑ | ↓ | N/A | N/A | N/A | 29 |
↑: upregulation; ↓: downregulation; ↓/↑: conflicting evidence; N/A: study not done.